About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at http://www.nxstage.com.
This release contains "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995. All statements
contained in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended to
identify forward-looking statements. Examples of these forward-looking
statements include statements as to the benefits of daily home
hemodialysis, expectations relating to our ability to build upon positive
clinical data relating to home daily hemodialysis, expectations regarding
our ability to update the data referenced on a semi-annual basis, and
expectations relating to improving patient and physician awareness, and
access to, home daily hemodialysis. All forward-looking statements involve
risks, uncertainties and contingencies, many of which are beyond NxStage's
|SOURCE NxStage Medical, Inc.|
Copyright©2008 PR Newswire.
All rights reserved